000 01370 a2200361 4500
005 20250515183539.0
264 0 _c20090915
008 200909s 0 0 eng d
022 _a0098-8588
024 7 _a10.1177/009885880903500202
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCrager, Sara E
245 0 0 _aUniversity contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
_h[electronic resource]
260 _bAmerican journal of law & medicine
_c2009
300 _a253-79 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aDeveloping Countries
650 0 4 _aDrug Industry
650 0 4 _aDrugs, Generic
_xsupply & distribution
650 0 4 _aFemale
650 0 4 _aHealth Services Accessibility
650 0 4 _aHealth Services Needs and Demand
650 0 4 _aHumans
650 0 4 _aPapillomavirus Vaccines
_xeconomics
650 0 4 _aPatents as Topic
650 0 4 _aSocioeconomic Factors
650 0 4 _aUniversities
650 0 4 _aUterine Cervical Neoplasms
_xmortality
700 1 _aGuillen, Ethan
700 1 _aPrice, Matt
773 0 _tAmerican journal of law & medicine
_gvol. 35
_gno. 2-3
_gp. 253-79
856 4 0 _uhttps://doi.org/10.1177/009885880903500202
_zAvailable from publisher's website
999 _c19099970
_d19099970